T1	Participants 744 847	53 patients in the experimental arm and 60 in the control arm who reported pain and fatigue at baseline
T2	Participants 145 384	patients undergoing an initial course of chemotherapy who report pain and fatigue at baseline and who are receiving conventional care alone with those receiving conventional care plus a nursing intervention on outcomes reported at 20 weeks
T3	Participants 394 468	Chemotherapy clinics of two comprehensive and two community cancer centers
